Trials / Completed
CompletedNCT05350930
Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Several experiences of multidisciplinary care pathways associating oncologists, pharmacists and nurses have been reported for cancer patients, with positive results on medication management safety, reduction of Drug-Related Problems (DRPs), and re-hospitalizations. This study aims to evaluate the impact of a multidisciplinary city-hospital follow-up program on medication management safety in haematological oncology patients receiving intravenous chemotherapy in onco-haematology. Additional aspects will be evaluated, such as the impact of the follow-up on the city-hospital link, satisfaction of patients and professionals involved in the follow-up and the use of telecare
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Assessment of patient satisfaction regarding tele-consultation | Questionnaire completed following the teleconsultation, if applicable. |
| OTHER | Literacy questionnaire | Questionnaire completed during hospitalization for the first chemotherapy cycle |
| OTHER | Collection of socio-demographic characteristics | Questionnaire completed during patient hospitalization for the first chemotherapy cycle |
| OTHER | Assessment of patient knowledge on chemotherapy side effects and support medications | Questionnaire completed during patient hospitalization for the first, second and sixth cycle of chemotherapy |
| OTHER | Assessment of patient satisfaction on pharmaceutical follow-up | Questionnaire completed during patient hospitalization for the sixth chemotherapy cycle |
Timeline
- Start date
- 2022-06-09
- Primary completion
- 2023-02-15
- Completion
- 2023-02-15
- First posted
- 2022-04-28
- Last updated
- 2025-03-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05350930. Inclusion in this directory is not an endorsement.